You should read both the consultation document and the accompanying evidence (see the committee papers) before making any comments. You must make your comments ...

The FDA approved Nemluvio for use in patients with moderate to severe atopic dermatitis in December, following an initial approval in prurigo nodularis in August. Galderma is now facing off ...

Dupixent's list of uses already includes asthma, eczema, chronic sinus inflammation with nasal polyps, eosinophilic food pipe inflammation, prurigo nodularis (hard, itchy bumps on the skin), and ...

The FDA approved dupilumab (Dupixent) for chronic spontaneous urticaria (CSU) in patients 12 years and older, the first new targeted drug for the inflammatory skin disease in over a decade ...

Nemluvio first won Food and Drug Administration approval in August for prurigo nodularis and subsequently received a greenlight for atopic dermatitis in December. The digital-first ad will run on both ...

In the U.S., there are more than 300,000 adults and adolescents aged 12 years and older living with CSU who remain symptomatic despite antihistamine treatment TARRYTOWN, N.Y. and PARIS, April 18 ...

The others are atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, prurigo nodularis and chronic obstructive pulmonary disease (COPD). Dupixent has been ...

eosinophilic esophagitis and prurigo nodularis. However, customary dynamics of the annual reset of insurance plans in the first quarter hurt sales slightly. Dupixent sales rose 23.5% in Europe and ...

1 Non-GAAP cost of product revenues excludes the amortization of licensed intellectual property for Iclusig relating to the acquisition of the European business of ARIAD Pharmaceuticals, Inc. and ...

1 Dupilumab was previously approved in the US for treatment of atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyposis, eosinophilic esophagitis, prurigo nodularis, and chronic ...

Beyond CSU, Dupixent is approved in the US for certain cases of atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic oesophagitis, prurigo nodularis and chronic ...